What Caught Our Attention in the Investment World? – Week of August 9-13, 2021
By Kuldip K. Ambastha BioNTech SE (BNTX) is aiming to become a leading biotechnology company with a main focus on individualized cancer medicine. The company has also been successful in offering an mRNA-based, two-shot coronavirus vaccine called BNT162b2 (aka: Comirnaty and Tozinameran), which has become increasingly important due to the rise of the highly contagious …
Continue reading “What Caught Our Attention in the Investment World? – Week of August 9-13, 2021”